What You Should Know:
- Vera Whole Health, Inc. and Castlight Health, Inc. appoints former Cerner President Donald Trigg as chief executive officer (CEO)
- In addition, the companies have rebranded as apree health that will be combine Castlight’s healthcare navigation platform with Vera’s advanced primary care solutions to improve patient outcomes and transform the healthcare industry.
Donald Trigg Background
Donald Trigg most recently served as president of
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Power Launches with $7M to Diversify Clinical Trials
What You Should Know:
- Power, a patient-friendly platform designed to improve access to clinical trial studies emerges from stealth with $7M in seed funding.
- The round was led by Footwork and CRV, with additional investments from ARTIS Ventures, South Park Commons, and AirAngels to help Power bring the process of discovering and accessing clinical trials into the future.
Modernising and Simplifying Accessibility to Clinical Trials
Eighty-six percent
Read More
Epicore & Denka Partner to Tackle Dehydration Crisis in Asia via Sweat-Sensing Wearable
What You Should Know:
- Epicore Biosystems today announced a partnership with Denka Corporation, a Japan-based multinational technology and materials company.
- Under the agreement, Epicore Biosystems and Denka will collaborate on strategic initiatives to pilot and distribute Epicore’s portfolio of advanced wearable hydration solutions in Japan and expand into Asia markets.
Tackling Asia’s Dehydration Crisis Through Sweat-Sensing Wearable Technology
Founded in 2017, Epicore
Read More
Medical Devices Cleared or Approved by FDA in 2022
The medical device industry is booming and shows no signs of slowing down. In 2022, the FDA (Federal Food and Drug Administration) will clear or approve over 1,000 medical devices. This is great news for patients who stand to benefit from the latest and greatest technology, but it can be tough for hospitals and doctors to keep up with all of the new devices on the market.
Here's a breakdown of some of the most anticipated otc medical devices that have already received FDA approval. Some
Read More
Realizing the Dream of AI in Clinical Trials—How to Address Key Challenges
The clinical development process is incredibly time consuming and only yields a success rate of about 10%. One way to reduce the time, cost and success of the clinical development process is to introduce artificial intelligence (AI) into clinical trials and implement AI-driven process automation.
The dream of AI in clinical trial execution is for trial functions to run autonomously, like a self-driving car. A self-driving car knows how fast it is going, where it needs to go,
Read More
Using AI to Match Patients with Clinical Trials for Proactive Treatment
We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More
Connected Devices Selection: Considerations for A Digital-First Approach to Data Collection
In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to the overarching industry shift toward patient-centricity, but in some cases, it is also due to the commercial availability of powerful technology solutions not previously feasible for use in medical devices. In the past, nearly all patient data have traditionally been acquired by purpose-built machines manufactured by relatively small-scale
Read More
H1 & Lokavant Partner to Power Next-Gen Clinical Trials
What You Should Know:
- H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development
- As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.
Integrating Clinical Trial Data Sources to Intelligence Platforms
Lokavant is a clinical
Read More
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Cleerly Raises $192M for AI-Driven Precision Heart Health Platform
What You Should Know:
- Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192M
- This new funding, led by led by funds and accounts advised by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc., and Fidelity Management and Research Company, brings the total raised by the fast-growing health care company to $248M, which includes its Series B round in 2021
AI-enabled Approach
Read More
